Heron Therapeutics (HRTX) P/FCF US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
P/FCF | -14.6 | -10.0 | -4.36 | -1.83 | -3.89 | -4.53 | |||
Changes by years, y/y, % | +54% | -31% | -57% | -58% | +113% | -16.3% |
Heron Therapeutics. P/FCF
Heron Therapeutics. P/FCF, changes, %
Heron Therapeutics (HRTX) P/FCF US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
P/FCF | -1.09 | -1.49 | -4.23 | -9.36 | -23.7 | -4.53 | ||
Changes by years, y/y, % | -34% | -51% | +111% | +570% | +2 075% | |||
Changes by quarters, q/q, % | -22% | +37% | +185% | +121% | +153% |